Abstract P6-18-24: Lapatinib-based therapies after pertuzumab and/or T-DM1 for HER2+ metastatic breast cancer patientsSimona Frezzini, Valentina Guarneri, Tommaso Giarratano et al.|Cancer Research|2019Cited by 0
Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched studyMaria Vittoria Dieci, Tania Saibene, Federica Miglietta et al.|Annals of Oncology|2019Cited by 0